Apricus appoints Barbara Troupin CMO
This article was originally published in Scrip
Apricus Biosciences, a biopharmaceutical company developing therapies in the areas of urology and rheumatology, has appointed Dr Barbara Troupin chief medical officer. Dr Troupin joins Apricus from Vivus where she has held various senior management roles since 2006. She will report to Apricus CEO Richard Pascoe.